Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1)

被引:36
作者
Hooijberg, JH
Jansen, G
Assaraf, YG
Kathmann, I
Pieters, R
Laan, AC
Veerman, AJP
Kaspers, GJL
Peters, GJ
机构
[1] Vrije Univ Amsterdam, Ctr Med, Dept Pediat Hematol Oncol, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Ctr Med, Dept Rheumatol, NL-1081 HV Amsterdam, Netherlands
[3] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel
[4] Vrije Univ Amsterdam, Ctr Med, Dept Med Oncol, NL-1081 HV Amsterdam, Netherlands
[5] Sophia Childrens Univ Hosp, Dept Pediat Oncol, Rotterdam, Netherlands
关键词
MRP1; ABCC1; folate; methotrexate; L-leucovorin; multidrug resistance; polyglutamylation; daunorubicin;
D O I
10.1016/j.bcp.2003.12.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Multidrug Resistance Protein MRP1 (ABCC1) can confer resistance to a variety of therapeutic drugs. In addition, MRP1/ABCC1 mediates cellular export of natural folates, such as folic acid and L-leucovorin. In this study we determined whether cellular folate status affected the functional activity of MRP1/ABCC1 mediated efflux of an established substrate, the anthracycline daunorubicin (DNR). As a model system we used the human ovarian carcinoma cell line 2008wt, and its MRP1/ABCC1 transfected subline 2008/MRP1 Both types of these moderate- and high-MRP1/ABCC1 expressing cells displayed efflux of DNR when maintained in standard culture media (2.3 muM folic acid). The initial total cellular DNR efflux rate in 2008/MRP1 cells was similar to2-fold higher compared to 2008wt cells. This efflux consisted of MRP1/ABCC1 mediated transport, possibly non-MRP1 mediated transport, as well as passive diffusion. Benzbromarone, a specific MRP1 inhibitor, decreased the initial efflux rate in 2008/MRP1 cells (4-fold) and in 2008wt cells (2-fold). When 2008/MRP1 cells were challenged for 2 days in folate-free medium, total cellular DNR efflux was decreased to 43% of the initial efflux rate under folate-rich conditions. In 2008wt cells DNR efflux was decreased to 84% of the folate-rich conditions. Benzbromarone did not inhibit DNR efflux after the folate-free period in both cell lines. Repletion of folate by a 2-24 hr exposure to 2.5 muM L-leucovorin or folic acid resulted in a complete restoration of DNR efflux. In contrast, expression of MRP1/ABCC1 protein was not changed significantly during the folate-free period or the repletion-period, nor were cellular ATP or ADP pools. In conclusion, this study demonstrates that the cellular folate status can influence the transport activity of MRP1/ABCC1. These results have potentially important implications in the understanding of the (patho-)physiological roles of MRP1/ABCC1, and possibly other ABC transporter proteins in cellular folate homeostasis and drug resistance. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1541 / 1548
页数:8
相关论文
共 43 条
[1]   Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells [J].
Assaraf, YG ;
Rothem, L ;
Hooijberg, JH ;
Stark, M ;
Ifergan, I ;
Kathmann, I ;
Dijkmans, BAC ;
Peters, GJ ;
Jansen, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :6680-6686
[2]  
Bergman AM, 1996, CLIN CANCER RES, V2, P521
[3]   ODE TO METHOTREXATE [J].
BERTINO, JR .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (01) :5-14
[4]   Mammalian ABC transporters in health and disease [J].
Borst, P ;
Elferink, RO .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :537-592
[5]   The multidrug resistance protein family [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1461 (02) :347-357
[6]   DAUNOMYCIN ACCUMULATION IN RESISTANT TUMOR-CELLS AS A SCREENING MODEL FOR RESISTANCE MODIFYING DRUGS - ROLE OF PROTEIN-BINDING [J].
BROXTERMAN, HJ ;
KUIPER, CM ;
SCHUURHUIS, GJ ;
VANDERHOEVEN, JJM ;
PINEDO, HM ;
LANKELMA, J .
CANCER LETTERS, 1987, 35 (01) :87-95
[7]  
Chen ZS, 2002, CANCER RES, V62, P3144
[8]   Molecular therapeutics - Methotrexate and its mechanism of action [J].
Cronstein, BN .
ARTHRITIS AND RHEUMATISM, 1996, 39 (12) :1951-1960
[9]   New insights into fibrin (ogen) structure and function [J].
Everse, SJ .
VOX SANGUINIS, 2002, 83 :375-382
[10]  
Habeck LL, 1998, CANCER CHEMOTH PHARM, V41, P201